NM_006517.5:c.-129G>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006517.5(SLC16A2):c.-129G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000378 in 793,147 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006517.5 5_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 exomes AF: 0.00000871 AC: 1AN: 114842Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 37728
GnomAD4 exome AF: 0.00000378 AC: 3AN: 793147Hom.: 0 Cov.: 13 AF XY: 0.00 AC XY: 0AN XY: 219605
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.94G>A (p.E32K) alteration is located in exon 1 (coding exon 1) of the SLC16A2 gene. This alteration results from a G to A substitution at nucleotide position 94, causing the glutamic acid (E) at amino acid position 32 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at